Page 58 - AN-2-1
P. 58

Advanced Neurology                                     Restless legs syndrome in end-stage renal disease patients




                             End-stage renal disease
                               patients (N=924)
                                                  Age < 18 years old (N=6)
                                                  Age > 80-year-old (N=17)
                                                  Did not met the diagnostic criteria for chronic renal failure with
                                                  uremia (N=72)
                                                  Did not receive maintenance hemodialysis 3 times per week, 4 hours
                                                  per time and for a period of over 3 months (N=86)

                                                   Did not use the same hemodialysis and dialyzer (N=54)
                                                   Noy in stable condition during the study (N=36)


                         End-stage renal disease patients on
                         maintenance hemodialysis (N=653)

                                                 Disturbance of consciousness (N=21), severe dysarthria (N=25),
                                                 aphasia and cognitive disorders (N=17)
                                                 Severe auditory or visual impairment, and physical frailty that
                                                 prevented interview attendance (N=37)
                         End-stage renal disease patients on
                         maintenance hemodialysis (N=553)

                                                 Severe comorbid diseases (e.g., heart disease, lung disease,
                                                 liver disease, kidney dysfunction, nutritional deficiency,
                                                 electrolyte disorder, severe endocrine and infectious diseases and
                                                 neuropsychiatric complications and mental illness) that could affect
                                                 follow-up assessment (N=67)
                                                 Nearly a month to take may affect the cognitive function, quality of life
                                                 and sleep quality of neuropsychiatric disorders and the application of
                                                 antipsychotics, dopamine agonists, nerves nutritional drugs, etc (N=58)


                                                 History of a central nervous system disease (such as tumor [N=17],
                                                 trauma [N=13], hydrocephalus [N=23], Parkinson’s disease [N=11],
                                                 dementia [N=14]), malignancies (N=7), HIV and opportunistic infections (N=2)
                                                 Did not provide comprehensive records and lost to follow-up (N=31)
                                                 Refused to participate and sign the written consent (N=24)
                            Patients in final study
                                 (N=286)

            Figure 1. Flow chart of study search and selection. “→” indicates exclusion criteria.
            2.2.3. Short form 36 (SF-36) health survey         result in a single global score. Lower ratings indicate better
            The SF-36 was used to assess quality of life. The data from   sleep quality. A global score of 5 or higher implies clinically
            36 items in eight subscales were integrated to measure the   severe sleep disruption.
            nutrition-associated quality  of life in  eight  dimensions:   2.3. Statistical methods
            Physical functioning, emotional role, physiological pain,
            general health, vitality, social functioning, and mental health.   The  SPSS 20.0  statistical  program was  used  to analyze
            The SF-36 total score ranges from 0 to 100. The higher the   the data. The mean, standard deviation, or median
            score, the greater the quality of life; otherwise, the worse.  (interquartile range) represent numerical data, while
                                                               percentages are used to express data of categorical variables.
            2.2.4. Assessment of sleep quality                 To investigate differences between continuous variables, the
            The Pittsburgh sleep quality index (PSQI) is a method for   Student’s t-test for normally distributed data and the Mann–
            measuring sleep quality. Seven component ratings ranging   Whitney  U-test for non-normally distributed variables
            from 0 to 3 are generated from 19 individual items. PSQI   were employed. Correlation analysis also be performed
            may be classified into seven factors: subjective sleep   to better describe the RLS-sleep or RLS-quality of life
            quality, sleep latency, sleep length, habitual sleep efficiency,   association. In contrast, the Fisher’s exact test was used to
            sleep disruption, usage of sleep medication, and daytime   analyze correlations between categorical variables. P < 0.05
            dysfunction. The total scores for these seven components   indicates that the difference was statistically significant.


            Volume 2 Issue 1 (2023)                         3                          https://doi.org/10.36922/an.210
   53   54   55   56   57   58   59   60   61   62   63